Evaluating the Concomitant Use of Diltiazem or Verapamil With Direct Oral Anticoagulants: A Meta-analysis
This meta-analysis found that the concomitant therapy of DOACs with diltiazem/verapamil increases the risks of bleeding outcomes compared with the DOAC monotherapy group.
Authors
- Kazuhiko Kido (ORCID: https://orcid.org/0000-0002-3393-8025)
- Mikiko Shimizu
- Tsuyoshi Shiga (ORCID: https://orcid.org/0000-0003-0358-7196)
- Masayuki Hashiguchi
Institutions
- Jikei University School of Medicine (JP)
- West Virginia University (US)
- Shujitsu University (JP)
Publication Details
- Journal
- Annals of Pharmacotherapy
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1177/10600280251323955
- Citations
- 2
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.78